| scholarly article | Q13442814 |
| P2093 | author name string | Sérgio Tufik | |
| Reinaldo N Takahashi | |||
| Orlando Francisco Amodeo Bueno | |||
| Ester Miyuki Nakamura-Palacios | |||
| P2860 | cites work | Muscarinic and nicotinic effects on yawning and tongue protruding in the rat | Q70797748 |
| Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning | Q71498535 | ||
| Involvement of catecholamine receptor activities in modulating the incidence of yawning in rats | Q71521259 | ||
| Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats | Q72551932 | ||
| Effects of Cannabis sativa (marihuana) on maze performance of the rat | Q72559623 | ||
| Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat | Q72579753 | ||
| Antagonism of an indirectly acting agonist: Block by propranolol and sotalol of the action of tyramien on rat heart | Q72859005 | ||
| Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice | Q73264277 | ||
| Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor | Q73704501 | ||
| Potentiation of anandamide hypotension by the transport inhibitor, AM404 | Q73922926 | ||
| The effects of cannabinoids on the brain | Q28137626 | ||
| An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing | Q28235579 | ||
| Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
| A second endogenous cannabinoid that modulates long-term potentiation | Q28248073 | ||
| Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 | ||
| Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen | Q28372719 | ||
| Repeated administration of delta9-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the rat | Q28374359 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| SR141716A, a potent and selective antagonist of the brain cannabinoid receptor | Q34332716 | ||
| Pharmacology of cannabinoid CB1 and CB2 receptors. | Q34442847 | ||
| The gastrointestinal pharmacology of cannabinoids. | Q34471097 | ||
| Mesolimbic dopaminergic decline after cannabinoid withdrawal | Q34750833 | ||
| Yawning | Q40573169 | ||
| Role of cyclic AMP in the actions of cannabinoid receptors | Q41090638 | ||
| The neuropharmacology of yawning | Q41743588 | ||
| Excitatory transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of cannabinoid CB1 receptors | Q41904764 | ||
| Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain | Q42541382 | ||
| delta-9-Tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat. | Q42548403 | ||
| Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum | Q43158845 | ||
| Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus | Q43175340 | ||
| Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain | Q43542613 | ||
| Marijuana receptor gene cloned | Q43586961 | ||
| Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction | Q43668148 | ||
| Aversive behavior during intraoral intake in male rats | Q43743032 | ||
| Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats | Q43970071 | ||
| delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors | Q44345904 | ||
| Neuroleptic-like profile of the cannabinoid agonist, HU 210, on rodent behavioural models | Q45711992 | ||
| AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain | Q46220923 | ||
| Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol | Q47870176 | ||
| Does REM sleep deprivation induce subsensitivity of presynaptic dopamine or postsynaptic acetylcholine receptors in the rat brain? | Q48220532 | ||
| Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats | Q48364151 | ||
| Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A. | Q48382273 | ||
| Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat. | Q48412912 | ||
| Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors | Q48518726 | ||
| Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A. | Q48704955 | ||
| Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices | Q48726145 | ||
| Anandamide: a candidate neurotransmitter heads for the big leagues. | Q51090766 | ||
| Influence of the cannabinoid agonist HU 210 on cocaine- and CQP 201-403-induced behavioural effects in rat. | Q51443626 | ||
| Effects of the cannabinoid ligand SR 141716A alone or in combination with delta9-tetrahydrocannabinol or scopolamine on learning in squirrel monkeys. | Q52144037 | ||
| Apomorphine-induced flavor-drug associations: a dose-response analysis by the taste reactivity test and the conditioned taste avoidance test. | Q52242046 | ||
| Changes in brain muscarinic acetylcholine receptors and behavioral responses to atropine and apomorphine in chronic atropine-treated rats | Q66965236 | ||
| Alteration in the action of cholinergic and anti cholinergic drugs after chronic haloperidol: Indirect evidence for cholinergic hyposensitivity | Q67440465 | ||
| The demonstration of a change in responsiveness of mice to physostigmine and atropine after withdrawal from long-term haloperidol pretreatment | Q67587116 | ||
| Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning | Q70394045 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoids | Q422936 |
| P304 | page(s) | 205-212 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Pharmacology, Biochemistry and Behavior | Q15716554 |
| P1476 | title | Acute or chronic effects of cannabinoids on spontaneous or pharmacologically induced yawning in rats | |
| P478 | volume | 74 |
| Q37590190 | Paradoxical sleep deprivation: neurochemical, hormonal and behavioral alterations. Evidence from 30 years of research |
| Q44567435 | Potentiation of penile erection and yawning responses to apomorphine by cannabinoid receptor antagonist in rats |
| Q52351694 | Yawning elicited by intravenous ethanol in rhesus monkeys with experience self-administering cocaine and ethanol: Involvement of dopamine D3 receptors. |
Search more.